BGM Group (NASDAQ:BGM) Shares Down 1.1% – What’s Next?

BGM Group Ltd. (NASDAQ:BGM) was down 1.1% during mid-day trading on Wednesday . The company traded as low as $0.3508 and last traded at $0.3635. 24,276 shares changed hands during trading, a decline of 96% from the average daily volume of 601,856 shares. The stock had previously closed at $0.3676.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of BGM Group in a research report on Monday, April 20th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

BGM Group Stock Performance

The stock’s 50-day simple moving average is $0.33 and its 200 day simple moving average is $1.48.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the company. Marshall Wace LLP acquired a new stake in BGM Group in the second quarter valued at about $218,000. Mariner LLC purchased a new stake in BGM Group in the 3rd quarter valued at approximately $267,000. Finally, Geode Capital Management LLC acquired a new position in BGM Group during the 2nd quarter worth approximately $412,000.

BGM Group Company Profile

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.